News
Nationwide Vehicle Contracts warns of fundamental industry shifts, with battery tech and servicing models set for overhaul as ...
UK van sales dropped 12.1% in H1 2025, with tax changes and weak economic confidence stalling fleet renewal and slowing the ...
Summit Therapeutics (SMMT) stock gains as AstraZeneca (AZN) is said to eye its lung cancer drug ivonescimab, a potential ...
Amid a tough economic environment and weak business confidence to invest in fleet renewal, the UK’s new LCV market continues ...
Around 18,944 cars made by Chinese-owned brands, including MG and Polestar, were sold in June, which is 10% of overall UK ...
Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...
4d
Zacks Investment Research on MSNWall Street Analysts Believe Summit Therapeutics (SMMT) Could Rally 63.02%: Here's is How to TradeShares of Summit Therapeutics PLC (SMMT) have gained 2.8% over the past four weeks to close the last trading session at $21.2 ...
6d
GlobalData on MSNUK vehicle production constraints affect May output: SMMTUK vehicle production continues to face constraints, with figures from the Society of Motor Manufacturers and Traders (SMMT) ...
Shares of Summit Therapeutics jumped 9% Thursday on a report that it was discussing a lucrative partnership deal with AstraZeneca.
Tesla's new car sales in Britain rose year-on-year in June amid a broader recovery in the electric-vehicle market, data showed on Friday, as the U.S. auto maker started deliveries of its updated Model ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results